JAMDA
Volume 11, Issue 3 , Pages 147-152 , March 2010

Hypertension: Is It Overtreated in the Elderly?

  • John E. Morley, MB, BCh

      Affiliations

    • Corresponding Author InformationAddress correspondence to John E. Morley, MB, BCh, Geriatric Medicine, Saint Louis University School of Medicine, 1402 S. Grand Boulevard, M238, St. Louis, MO 63104.

References 

  1. Rowland FN, Cowles M, Dickstein C, Katz PR. Impact of medical director certification on nursing home quality of care. J Am Med Dir Assoc. 2009;10:431–435
  2. Morley JE. Caring for the vulnerable elderly: Are available quality indicators appropriate?. J Am Med Dir Assoc. 2008;9:1–3
  3. Morley JE. Phronesis and the medical director. J Am Med Dir Assoc. 2009;10:149–152
  4. Flaherty JF, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. 2000;55:M549.
  5. Morley JE. Polypharmacy in the nursing home. J Am Med Dir Assoc. 2009;10:289–291
  6. Gokce Kutsal Y, Barak A, Atalay A, et al. Polypharmacy in the elderly: A multicenter study. J Am Med Dir Assoc. 2009;10:486–490
  7. Drinka PJ. Medications prescribed by specialists in nursing homes. J Am Med Dir Assoc. 2008;9:137–138
  8. Messinger-Rapport BJ, Thomas DR, Gammack JK, Morley JE. Clinical update on nursing home medicine. J Am Med Dir Assoc. 2009;10:530–553
  9. Turco R, Tropilliesi T, Morghen S, et al. Clinical complexity and Occam's razor: Navigating between Scylla and Charibdy of the geriatric practice. A case of secondary hypertension in a very old patient. J Am Med Dir Assoc. 2009;10:281–282
  10. Lester P, Haq M, Vadnerkar A, Feuerman M. Falls in the nursing home setting: Does time matter. J Am Med Dir Assoc. 2008;9:684–686
  11. Morley JE. Falls and fractures. J Am Med Dir Assoc. 2007;8:276–278
  12. Morley JE. A fall is a major event in the life of an older person. J Gerontol A Biol Sci Med Sci. 2002;57:M492–M495
  13. George-Saintilus E, Tommasulo B, Cal CE, et al. Pressure ulcer PUSH score and traditional nursing assessment in nursing home residents: Do they correlate?. J Am Med Dir Assoc. 2009;10:141–144
  14. Thomas DR. Prevention and treatment of pressure ulcers. J Am Med Dir Assoc. 2006;7:46–59
  15. Abellan van Kan G, Rolland YM, Morley JE, Vellas B. Frailty: Toward a clinical definition. J Am Med Dir Assoc. 2008;9:71–72
  16. Abellan van Kan G, Rolland Y, Bergman H, et al. The IANA Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging. 2008;12:29–37
  17. Morley JE. Developing novel therapeutic approaches to frailty. Curr Pharm Des. 2009;15:3384–3395
  18. Joseph J, Koka M, Aronow WS. Prevalence of a hemoglobin A1C less than 7.08, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home. J Am Med Dir Assoc. 2008;9:51–54
  19. Aronow WS. Hypertension in the nursing home. J Am Med Dir Assoc. 2008;9:486–490
  20. Ahmed A, Jones L, Hays CI. DEFEAT heart failure: Assessment and management of heart failure in nursing homes made easy. J Am Med Dir Assoc. 2008;9:383–389
  21. Cushman WC. JNC-7 guidelines: Are they still relevant?. Curr Hypertens Rep. 2007;9:380–386
  22. Moser M. From JNC I to JNC 7—what have we learned?. Prog Cardiovasc Dis. 2006;48:303–315
  23. Iwanczyk L, Weintraub NT, Rubenstein LZ. Orthostatic hypotension in the nursing home setting. J Am Med Dir Assoc. 2006;7:163–167
  24. Luukinen H, Koski K, Laippala P, Kivela SL. Prognosis of diastolic and systolic orthostatic hypotension in older persons. Arch Intern Med. 1999;159:273–280
  25. Beckett NS, Connor M, Sadler JD, et al. Orthostatic fall in blood pressure in the very elderly hypertensive: Results from the hypertension in the very elderly trial (HYVET)—pilot. J Hum Hypertens. 1999;13:839–840
  26. Deegan BM, O'Connor M, Lyons D, O'Laighin G. Development and evaluation of new blood pressure and heart rate signal analysis techniques to assess orthostatic hypotension and it subtypes. Physiol Meas. 2007;28:N87–N102
  27. Jansen RW, Kelly-Gagnon MM, Lipsitz LA. Intraindividual reproducibility of postprandial and orthostatic blood pressure changes in older nursing-home patients: Relationship with chronic use of cardiovascular medications. J Am Geriatr Soc. 1996;44:383–389
  28. Zuschke CA, Pettyjohn FS. Pseudohypertension. South Med J. 1995;88:1185–1190
  29. Anzal M, Palmer AJ, Starr J, Bulpitt CJ. The prevalence of pseudohypertension in the elderly. J Hum Hypertens. 1996;10:409–411
  30. Cheng TO. Osler maneuver to detect pseudohypertension. JAMA. 1999;282:943
  31. Wright JC, Looney SW. Prevalence of positive Osler's maneuver in 3387 persons screened for the Systolic Hypertension in the Elderly Program (SHEP). J Hum Hypertens. 1997;11:285–289
  32. Gentilcore D, Jones KL, O'Donovan DG, Horowitz M. Postprandial hypotension—novel insights into pathophysiology and therapeutic implications. Curr Vasc Pharmacol. 2006;4:161–171
  33. Jansen RW, Lipsitz LA. Postprandial hypotension: Epidemiology, pathophysiology, and clinical management. Ann Intern Med. 1995;122:286–295
  34. Morley JE. Postprandial hypotension—the ultimate Big Mac attack. J Gerontol A Biol Sci Med Sci. 2001;56:M741–M743
  35. Fisher AA, Davis MW, Srikusalanukul W, Budge MM. Postprandial hypotension predicts all-cause mortality in older, low-level care residents. J Am Geriatr Soc. 2005;53:1313–1320
  36. Edwards BJ, Perry HM, Kaiser FE, et al. Relationship of age and calcitonin gene-related peptide to postprandial hypotension. Mech Ageing Dev. 1996;87:61–73
  37. DeLeon MJ, Chandurkar V, Albert SG, Mooradian AD. Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects. Diabetes Res Clin Pract. 2002;56:101–106
  38. Lee A, Patrick P, Wishart J, et al. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab. 2002;4:329–335
  39. Jian ZJ, Zhou BY. Efficacy and safety of acarbose in the treatment of elderly patients with postprandial hypotension. Chin Med J (Engl). 2008;121:2054–2059
  40. Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50:54–61
  41. Verdecchia P, Angeli F, Gattobigio R, et al. The clinical significance of white-coat and masked hypertension. Blood Press Monit. 2007;12:387–389
  42. Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54:226–232
  43. Mulrow C, Lau J, Cornell J, Brand M. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2000;(2):CD000028
  44. Levenson SA, Morley JE. Evidence rocks in long-term care, but does it roll?. J Am Med Dir Assoc. 2007;8:493–501
  45. Mattila K, Haavisto M, Rajala S, Heikinheimo R. Blood pressure and five year survival in the very old. Br Med J Clin Res Ed. 1988;296:887–889
  46. Sorensen KH, Hilden T. Increased total mortality and decreased functional capacity are associated with low systolic blood pressure among elderly women. Scand J Prim Health Care. 1988;6:105–110
  47. Gueyffier F, Bulpitt C, Boissel JP, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. INDANA Group. Lancet. 1999;353:793–796
  48. Bulpitt CJ, Beckett NS, Cooke J, et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens. 2003;21:2409–2417
  49. Beckett NS, Peters R, Fletcher AE, et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898
  50. Peters R, Beckett N, Forette F, et al. HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial Cognitive Function Assessment (HYVET-COG): A double-blind, placebo controlled trial. Lancet Neurol. 2008;7:683–689
  51. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2009;(4): CD000028
  52. Meyers RM, Reger L. Diabetes management in long-term care facilities: A practical guide. J Am Med Dir Assoc. 2009;10:589
  53. Feldman SM, Rosen R, DeStasio J. Status of diabetes management in the nursing home setting in 2008: A retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management. J Am Med Dir Assoc. 2009;10:354–360
  54. Mazza AD, Morley JE. Update on diabetes in the elderly and the application of current therapeutics. J Am Med Dir Assoc. 2007;8:489–492
  55. Rosenthal MJ, Fajardo M, Gilmore S, et al. Hospitalization and mortality of diabetes in older adults. A 3-year prospective study. Diabetes Care. 1998;21:231–235
  56. Staessen JA, Fagard R, Thijs L, et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757–764
  57. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–3264
  58. Holman RR, Paul SK, Bethel MA, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565–1576
  59. Kopetschke R, Slisko M, Kilisli A, et al. Frequent incidental discovery of phaeochromocytoma: Data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol. 2009;161:355–361
  60. Dominguez LJ, Bevilacqua M, Dibella G, Barbagallo M. Diagnosing and managing thyroid disease in the nursing home. J Am Med Dir Assoc. 2008;9:9–17
  61. Yokokawa K, Tahara H, Kohno M, et al. Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann Intern Med. 1991;114:213–215
  62. Das AM, Khayat R. Hypertension in obstructive sleep apnea: Risk and therapy. Expert Rev Cardiovasc Ther. 2009;7:619–626
  63. Viera AJ, Hinderliter AL. Evaluation and management of the patient with difficult-to-control or resistant hypertension. Am Fam Physician. 2009;79:863–869
  64. Friedman O, Logan AG. Sympathoadrenal mechanisms in the pathogenesis of sleep apnea-related hypertension. Curr Hypertens Rep. 2009;11:212–216
  65. Resnick HE, Phillips B. Documentation of sleep apnea in nursing homes: United States 2004. J Am Med Dir Assoc. 2008;9:260–264
  66. Gonzaga CC, Calhoun DA. Resistant hypertension and hyperaldosteronism. Curr Hypertens Rep. 2008;10:496–503
  67. Mulatero P, Bertello C, Verhovez A, et al. Differential diagnosis of primary aldosteronism subtypes. Curr Hypertens Rep. 2009;11:217–223
  68. Lim MA, Townsend RR. Arterial compliance in the elderly: Its effect on blood pressure measurement and cardiovascular outcomes. Clin Geriatr Med. 2009;25:191–205
  69. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Medscape. Vitamin D status and arterial hypertension: A systematic review. Nat Rev Cardiol. 2009;6:621–630
  70. Perry HM, Horowitz M, Morley JE, et al. Longitudinal changes in serum 25-hydroxyvitamin D in older people. Metabolism. 1999;48:1028–1032
  71. Braddy KK, Imam SN, Palla KR, Lee TA. Vitamin D deficiency/insufficiency practice patterns in a Veterans Health Administration long-term care population: A retrospective analysis. J Am Med Dir Assoc. 2009;10:653–657
  72. Morley JE. Vitamin D redux. J Am Med Dir Assoc. 2009;10:591–592
  73. Bhutto A, Morley JE. The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care. 2008;11:651–660
  74. Morley JE. Should all long-term care residents receive vitamin D?. J Am Med Dir Assoc. 2007;8:69–70
  75. Volicer L. Behaviors in advanced dementia. J Am Med Dir Assoc. 2009;10:146
  76. Kaufer DI, Williams CS, Braaten AJ, et al. Cognitive screening for dementia and mild cognitive impairment in assisted living: Comparison of 3 tests. J Am Med Dir Assoc. 2008;9:586–593
  77. Rozzini R, Trabucchi M. Managing persons with dementia in the nursing home. J Am Med Dir Assoc. 2008;9:368
  78. Morley JE. Managing persons with dementia in the nursing home: High touch trumps high tech. J Am Med Dir Assoc. 2008;9:139–146
  79. Thakur M, Blazer DG. Depression in long-term care. J Am Med Dir Assoc. 2008;9:82–87
  80. Cervo FA, Bruckenthal P, Chen JJ, et al. Pain assessment in nursing home residents with dementia: Psychometric properties and clinical utility of the CAN Pain Assessment Tool (CPAT). J Am Med Dir Assoc. 2009;10:505–510
  81. Eeles E, Rockwood K. Delirium in the long-term care setting: Clinical and research challenges. J Am Med Dir Assoc. 2008;9:157–161
  82. Voyer P, Richard S, Doucet L, Carmichael PH. Detecting delirium and subsyndromal delirium using different diagnostic criteria among demented long-term care residents. J Am Med Dir Assoc. 2009;10:181–188
  83. Flaherty JH, Morley JE. Delirium: A call to improve current standards of care. J Gerontol A Biol Sci Med Sci. 2004;59:341–343
  84. Lewis LM, Miller DK, Morley JE, et al. Unrecognized delirium in ED geriatric patients. Am J Emerg Med. 1995;13:142–145
  85. Husebo BS, Strand LI, Moe-Nilssen R, et al. Who suffers most? Dementia and pain in nursing home patients: A cross-sectional study. J Am Med Dir Assoc. 2008;9:427–433
  86. Tait RC, Chibnall JT. Under-treatment of pain in dementia: Assessment is key. J Am Med Dir Assoc. 2008;9:372–374
  87. Keeney CE, Scharfenberger JA, O'Brien JG, et al. Initiating and sustaining and standardized pain management program in long-term care facilities. J Am Med Dir Assoc. 2008;9:347–353
  88. Morley JE, Thomas DR. Cachexia: New advances in the management of wasting diseases. J Am Med Dir Assoc. 2008;9:205–210
  89. Kumari J, Dharmarajan TS. Insulin glargine induced persistent intractable hypoglycemia, with variable presentations in older diabetic patients: An experience of 4 cases. J Am Med Dir Assoc. 2009;10:672–673
  90. Sloane PD, Ivey J, Helton M, et al. Nutritional issues in long-term care. J Am Med Dir Assoc. 2008;9:476–485
  91. Thomas DR. But is it malnutrition?. J Am Med Dir Assoc. 2009;10:295–297
  92. Morley JE. Decreased food intake with aging. J Gerontol A Biol Sci Med Sci. 2001;56:81–88
  93. Wilson MMG, Vaswani S, Liu D, et al. Prevalence and causes of undernutrition in medical outpatients. Am J Med. 1998;104:56–63
  94. Rolland Y, Kim MJ, Gammack JK, et al. Office management of weight loss in older persons. Am J Med. 2006;119:1019–1026
  95. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007;10:433–442
  96. Padiyar A. Nonpharmacologic management of hypertension in the elderly. Clin Geriatr Med. 2009;25:213–219
  97. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary dosium reduction on cardiovascular disease outcomes: Observational follow-up of trials of hypertension prevention (TOHP). BMJ. 2007;334:885–888
  98. Kagen A, Popper JS, Rhoads GG, Yano K. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke. 1985;16:390–396
  99. Cohen JD, Grandis G, Cutler JA, et al. Dietary sodium intake and mortality: MRFIT followup study results. Circulation. 1999;100:15–24
  100. Alderman MH, Madhavan S, Cohen H, et al. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995;25:1144–1152
  101. Cohen HW, Hailpern SM, Alderman MH. Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med. 2008;23:1297–1302
  102. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, Part I: History, examination, body composition, and screening tools. Nutrition. 2000;16:50–63
  103. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, Part II: Laboratory evaluation. Nutrition. 2000;16:131–140
  104. Wright JT, Dunn JK, Cutler JA, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293:1595–1608
  105. Moser M, Feig PU. Fifty years of thiazide diuretic therapy for hypertension. Arch Intern Med. 2009;169:1851–1856
  106. Thomas DR, Cote TR, Lawhorne L, et al. Dehydration Council. Understanding clinical dehydration and its treatment. J Am Med Dir Assoc. 2008;9:292–301
  107. Crecelius C. Dehydration: Myth and reality. J Am Med Dir Assoc. 2008;9:287–288
  108. Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc. 1995;43:1410–1413
  109. Wiysonge CS, Bradley H, Mayosi BM, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2007;(1):CD002003
  110. Go AS, Yang J, Gurwitz JH, et al. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med. 2008;168:2415–2421
  111. Kramer JM, Curtis LH, Dupree CS, et al. Comparative effectiveness of beta-blockers in elderly patients with heart failure. Arch Intern Med. 2008;168:2422–2428
  112. Yusuf S, Teo KK, Pogue J, et al. ONTARGET Investigators Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547–1559
  113. Fraser HS. Reserpine: A tragic victim of myths, marketing, and fashionable prescribing. Clin Pharmacol Ther. 1996;60:368–373
  114. Griebenow R, Pittrow DB, Weidinger G, et al. Low-dose reserpine/thiazide combination in first-line treatment of hypertension: Efficacy and safety compared to an ACE inhibitor. Blood Press. 1997;6:299–306
  115. Krönig B, Pittrow DB, Kirch W, et al. Different concepts in first-line treatment of essential hypertension. Comparison of a low-dose reserpine-thiazide combination with nitrendipine monotherapy. German Reserpine in Hypertension Study Group. Hypertension. 1997;29:651–658
  116. Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B. Dietary nitrate reduces maximal oxygen consumption while maintaining work performance in maximal exercise. Free Radic Biol Med. 2009;Nov 12 [Epub ahead of print]

PII: S1525-8610(09)00517-9

doi: 10.1016/j.jamda.2009.12.081

JAMDA
Volume 11, Issue 3 , Pages 147-152 , March 2010